143 related articles for article (PubMed ID: 35569011)
1. Rodent models to study sodium retention in experimental nephrotic syndrome.
Xiao M; Bohnert BN; Grahammer F; Artunc F
Acta Physiol (Oxf); 2022 Jul; 235(3):e13844. PubMed ID: 35569011
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome.
Xiao M; Bohnert BN; Aypek H; Kretz O; Grahammer F; Aukschun U; Wörn M; Janessa A; Essigke D; Daniel C; Amann K; Huber TB; Plow EF; Birkenfeld AL; Artunc F
Acta Physiol (Oxf); 2021 Jan; 231(1):e13512. PubMed ID: 32455507
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome.
Bohnert BN; Menacher M; Janessa A; Wörn M; Schork A; Daiminger S; Kalbacher H; Häring HU; Daniel C; Amann K; Sure F; Bertog M; Haerteis S; Korbmacher C; Artunc F
Kidney Int; 2018 Jan; 93(1):159-172. PubMed ID: 29042083
[TBL] [Abstract][Full Text] [Related]
4. Sodium retention in nephrotic syndrome is independent of the activation of the membrane-anchored serine protease prostasin (CAP1/PRSS8) and its enzymatic activity.
Essigke D; Bohnert BN; Janessa A; Wörn M; Omage K; Kalbacher H; Birkenfeld AL; Bugge TH; Szabo R; Artunc F
Pflugers Arch; 2022 Jun; 474(6):613-624. PubMed ID: 35312839
[TBL] [Abstract][Full Text] [Related]
5. Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin.
Bohnert BN; Artunc F
J Vis Exp; 2018 May; (135):. PubMed ID: 29782000
[TBL] [Abstract][Full Text] [Related]
6. Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome.
Artunc F; Wörn M; Schork A; Bohnert BN
Acta Physiol (Oxf); 2019 Apr; 225(4):e13249. PubMed ID: 30597733
[TBL] [Abstract][Full Text] [Related]
7. Experimental nephrotic syndrome leads to proteolytic activation of the epithelial Na
Bohnert BN; Essigke D; Janessa A; Schneider JC; Wörn M; Kalo MZ; Xiao M; Kong L; Omage K; Hennenlotter J; Amend B; Birkenfeld AL; Artunc F
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F480-F493. PubMed ID: 34423678
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome.
Larionov A; Dahlke E; Kunke M; Zanon Rodriguez L; Schiessl IM; Magnin JL; Kern U; Alli AA; Mollet G; Schilling O; Castrop H; Theilig F
J Cell Mol Med; 2019 Oct; 23(10):6543-6553. PubMed ID: 31368174
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
[TBL] [Abstract][Full Text] [Related]
10. Regulation of epithelial sodium channel in puromycin aminonucleoside-induced unilateral experimental nephrotic syndrome in normal and analbuminemic Nagase rats.
Yu Z; Schumacher M; Frey BM; Frey FJ; Vogt B
Nephron Physiol; 2005; 101(3):p51-62. PubMed ID: 16020936
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice.
Artunc F; Bohnert BN; Schneider JC; Staudner T; Sure F; Ilyaskin AV; Wörn M; Essigke D; Janessa A; Nielsen NV; Birkenfeld AL; Etscheid M; Haerteis S; Korbmacher C; Kanse SM
Pflugers Arch; 2022 Feb; 474(2):217-229. PubMed ID: 34870751
[TBL] [Abstract][Full Text] [Related]
12. Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice.
Haerteis S; Schork A; Dörffel T; Bohnert BN; Nacken R; Wörn M; Xiao M; Essigke D; Janessa A; Schmaier AH; Feener EP; Häring HU; Bertog M; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2018 Sep; 224(1):e13060. PubMed ID: 29489063
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of sodium retention in nephrotic syndrome.
Hinrichs GR; Jensen BL; Svenningsen P
Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):207-212. PubMed ID: 31789848
[TBL] [Abstract][Full Text] [Related]
14. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
[TBL] [Abstract][Full Text] [Related]
15. Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium.
Dizin E; Olivier V; Maire C; Komarynets O; Sassi A; Roth I; Loffing J; de Seigneux S; Maillard M; Rutkowski JM; Edwards A; Feraille E
FASEB J; 2020 Feb; 34(2):2408-2424. PubMed ID: 31908015
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats.
Kim SW; Wang W; Nielsen J; Praetorius J; Kwon TH; Knepper MA; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2004 May; 286(5):F922-35. PubMed ID: 15075188
[TBL] [Abstract][Full Text] [Related]
17. Increased expression but not targeting of ENaC in adrenalectomized rats with PAN-induced nephrotic syndrome.
de Seigneux S; Kim SW; Hemmingsen SC; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F208-17. PubMed ID: 16403831
[TBL] [Abstract][Full Text] [Related]
18. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis.
Lourdel S; Loffing J; Favre G; Paulais M; Nissant A; Fakitsas P; Créminon C; Féraille E; Verrey F; Teulon J; Doucet A; Deschênes G
J Am Soc Nephrol; 2005 Dec; 16(12):3642-50. PubMed ID: 16267158
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
Hinrichs GR; Weyer K; Friis UG; Svenningsen P; Lund IK; Nielsen R; Mollet G; Antignac C; Bistrup C; Jensen BL; Birn H
Acta Physiol (Oxf); 2019 Dec; 227(4):e13362. PubMed ID: 31423748
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic Activity against the Distal Polybasic Tract of the Gamma Subunit of the Epithelial Sodium Channel ENaC in Nephrotic Urine.
Wörn M; Kalbacher H; Artunc F
Curr Med Chem; 2022; 29(42):6433-6445. PubMed ID: 35676854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
